Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis

The development of tumor lysis syndrome (TLS) in association with treatment for myeloproliferative neoplasms (MPNs) is relatively rare. We herein present the case of a post-polycythemia vera (PV) myelofibrosis patient with massive splenomegaly who developed laboratory TLS after treatment with ruxoli...

Full description

Saved in:
Bibliographic Details
Published in:Intern Med
Main Authors: Koshiishi, Megumi, Sueki, Yuki, Kawashima, Ichiro, Nakajima, Kei, Mitsumori, Toru, Kirito, Keita
Format: Artigo
Language:Inglês
Published: The Japanese Society of Internal Medicine 2017
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635310/
https://ncbi.nlm.nih.gov/pubmed/28794380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8706-16
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items